Leads $50 Mln Series B Financing For Evommune
27/04/2023 08:36
April 27 (Reuters) - Arix Bioscience PLC ARIX.L :
* ARIX BIOSCIENCE PLC - ARIX CO-LEADS $50 MILLION SERIES B
FINANCING FOR NEW PORTFOLIO COMPANY EVOMMUNE
Source text for Eikon: ID:nEQ2BN9XRa
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co